Lijekovi-lijek generičkog naziva omaveloksolon
TED · 641366-2026Award noticeawardedNo deadline given
Value
Estimated€1,096,935 · 1,096,935 EUR
Awarded€825,030 · 825,030.14 EUR
WinnerMEDIKA, d.d.
Who already wins at this buyer
Firms with recorded awards from Klinički bolnički centar Zagreb in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| MEDIKA, d.d. | 7 | €13,959,466 | 2026-10-13 |
| ROCHE d.o.o. | 5 | €1,519,117 | 2026-09-22 |
| MEDICAL INTERTRADE d.o.o. | 3 | €2,386,017 | 2026-09-23 |
| JASIKA d.o.o. | 3 | €494,990 | 2026-09-23 |
| KEFO d.o.o. | MEDICAL INTERTRADE d.o.o. | BIOMEDICA DIJAGNOSTIKA d.o.o. | ROCHE d.o.o. | BIOVIT d.o.o. | GOREA PLUS d.o.o. | JASIKA d.o.o. | BIOSISTEMI d.o.o. | 2 | €1,885,337 | 2026-08-17 |
Full buyer profile: what Klinički bolnički centar Zagreb buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Lijekovi-lijek generičkog naziva omaveloksolon
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-17 | Lijekovi - lijek generičkog naziva givinostat | Klinički bolnički centar Zagreb HR | 94% |
| 2026-10-13 | Lijekovi- lijek generičkog naziva nivolumab | Klinički bolnički centar Zagreb HR | 94% |
| 2026-09-17 | Lijekovi - lijek generičkog naziva pembrolizumab | Klinički bolnički centar Zagreb HR | 94% |
| 2026-09-17 | Lijekovi - lijek generičkog naziva zanubrutinib | Klinički bolnički centar Zagreb HR | 93% |
| 2026-10-02 | Lijek Mosunetuzumab | Klinička bolnica Merkur HR | 92% |
| 2026-08-12 | Lijekovi frukvintinib - iznimna žurnost | Klinički bolnički centar Rijeka HR | 92% |